Clinical Trial Update: Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")

View source ↗

Summary

The document reports results from the completed SHAC Neuro Study evaluating neurocognitive effects and tolerability of efavirenz in aging HIV-infected individua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immune Deficiency Syndrome
• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)

Snippet

Sponsor: Stanford University | Conditions: HIV, AIDS | Status: COMPLETED